No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial

We have reported previously that after 1-year follow up, gonadotropin-releasing hormone agonist (GnRHa) did not prevent chemotherapy-induced premature ovarian failure (POF) in patients with lymphoma, but may provide protection of the ovarian reserve. Here, we report the final analysis of the cohort...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical oncology 2016-08, Vol.34 (22), p.2568-2574
Hauptverfasser:	Demeestere, Isabelle, Brice, Pauline, Peccatori, Fedro A, Kentos, Alain, Dupuis, Jehan, Zachee, Pierre, Casasnovas, Olivier, Van Den Neste, Eric, Dechene, Julie, De Maertelaer, Viviane, Bron, Dominique, Englert, Yvon
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Female Fertility - drug effects Fertility Preservation - methods Gonadotropin-Releasing Hormone - agonists Humans Lymphoma - drug therapy Middle Aged Norethindrone - therapeutic use Ovary - drug effects Ovary - physiology Primary Ovarian Insufficiency - prevention & control Prospective Studies Triptorelin Pamoate - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!